Germany · Venture startup

Who invested in Caire

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$889Kraised across 2 rounds since 2025, from 2 sources

Latest round
VentureJun 2025
Biggest round
$889KPre-seed · Feb 2025
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026
$889KPre-seed?Venture
First round
Pre-seed, $889K
Feb 2025
Biggest round
$889K
Pre-seed · Feb 2025
Between rounds
4 months
from the last two

The rounds

  1. Jun 2025
    VentureAmount undisclosed1 returning

    Source recorded

  2. Feb 2025
    Pre-seed$889K1 new

    Source recorded

Founders and team

From Caire's own website: 3 founders, 1 on the team.

Hamdi BelhassenCEO & Co-Founder
Daniel AngloherHead of AI and Co-Founder
Hoai Nam CoFounder associate
  • Dr. Houda DaaloulChief Medical Officer

Everyone who backed them

Bayern KapitalGovernment2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Caire

Who invested in Caire?

Caire's investors include Bayern Kapital.

How much has Caire raised?

Caire has raised $889K across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.

When did Caire last raise?

Caire's most recent round was a Venture in Jun 2025.

What was Caire's biggest round?

Caire's largest round on record is $889K (Pre-seed), in Feb 2025.

Who backed Caire first?

Caire's first round on record, in Feb 2025, was backed by Bayern Kapital.

What stage is Caire at?

Caire's latest named round is a Venture, in Jun 2025.

Where is Caire based?

Caire is based in Germany.

Companies like Caire

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.